Selumetinib benefits children with inoperable plexiform neurofibromas
Crossref DOI link: https://doi.org/10.1038/s41571-020-0361-7
Published Online: 2020-03-31
Published Print: 2020-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Killock, David
Text and Data Mining valid from 2020-03-31
Version of Record valid from 2020-03-31
Article History
First Online: 31 March 2020